Study Using the ShiraTronics Migraine Therapy System
NCT05700318 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-07-16
Summary
The purpose of this pilot study is to assess the preliminary safety and efficacy of the ShiraTronics Migraine Therapy System in prophylactic treatment of patients with refractory chronic migraine.
Conditions
- Chronic Migraine, Headache
Interventions
- DEVICE
-
neurostimulator
The ShiraTronics Migraine Therapy System
Sponsors & Collaborators
-
ShiraTronics
lead INDUSTRY
Principal Investigators
-
Scientific Advisory Board · ShiraTronics
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-05
- Primary Completion
- 2025-03-31
- Completion
- 2025-03-31
- FDA Device
- Yes
Countries
- Australia
Study Locations
More Related Trials
-
eNeura SpringTMS Post-Market Observational US Study of Migraine
NCT02357381 ·Status: COMPLETED
-
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
NCT05769348 ·Status: RECRUITING ·Phase: NA
-
A Study of Remote Electrical Neuromodulation for Acute Procedural Pain
NCT05730556 ·Status: TERMINATED ·Phase: NA
-
Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine
NCT05161871 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine
NCT04194008 ·Status: COMPLETED ·Phase: NA
-
REsponse to Combined SONS and ONS in Chronic Cluster headachE
NCT05868044 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine
NCT04584762 ·Status: UNKNOWN ·Phase: NA
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.
NCT03185559 ·Status: TERMINATED ·Phase: NA
-
Intranasal Cooling for Symptomatic Relief of Migraine
NCT02375789 ·Status: TERMINATED ·Phase: NA
-
Chordate System Prophylactic Migraine Clinical Investigation
NCT02243865 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Neurostimulation for the Prevention of Chronic Migraine
NCT01667250 ·Status: COMPLETED ·Phase: NA
-
Migraine Prevention Using ActiPatch
NCT03166046 ·Status: COMPLETED ·Phase: NA
-
Abortive Treatment of Migraine With the Cefaly® Abortive Program Device
NCT03217968 ·Status: COMPLETED ·Phase: NA
-
The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras
NCT01080287 ·Status: COMPLETED
-
Migraine Treatment With Nerivio Migra Neurostimulation Device
NCT03076515 ·Status: TERMINATED ·Phase: NA
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine
NCT02120326 ·Status: COMPLETED ·Phase: NA
-
A Study of LY3451838 in Participants With Migraine
NCT04498910 ·Status: COMPLETED ·Phase: PHASE2
-
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
NCT02991430 ·Status: TERMINATED ·Phase: NA
-
Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine
NCT02725554 ·Status: WITHDRAWN ·Phase: PHASE3
-
Chordate System S020 Acute Migraine Clinical Investigation
NCT02185703 ·Status: TERMINATED ·Phase: NA
-
Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines
NCT03036761 ·Status: COMPLETED ·Phase: NA
-
Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
NCT07191145 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluation of a New Treatment for Migraine Attacks
NCT01880671 ·Status: COMPLETED ·Phase: NA